TCL Archive In Brief: Three More Comprehensive Centers May Be Names; Hawaii, Cleveland, Ohio State Lead List of 10 May 9, 1975
TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010